Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move

Here are some of the biggest movers of Monday.

Stock gainers:

Biogen Inc. shares
BIIB,
+1.31%
rallied 5% following a full-day halt during the regular session as a Food and Drug Administration committee convened to vote on an approval recommendation for the biotech’s Alzheimer’s drug candidate it makes with Eisai Co.
ESALF,
+9.35%
The committee voted unanimously to recommend approval, and Biogen shares took off when they were unhalted.